Elicio Therapeutics, Inc. (ELTX)
2.41
-0.09
(-3.60%)
USD |
NASDAQ |
Sep 04, 16:00
2.425
+0.02
(+0.62%)
After-Hours: 20:00
Elicio Therapeutics Cash and Short Term Investments (Annual) : 18.56M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 18.56M |
| December 31, 2024 | 18.80M |
| December 31, 2023 | 13.62M |
| December 31, 2022 | 7.797M |
| December 31, 2021 | 88.76M |
| December 31, 2020 | 34.61M |
| December 31, 2019 | 5.571M |
| Date | Value |
|---|---|
| December 31, 2018 | 25.51M |
| December 31, 2017 | |
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | 2.057M |
| December 31, 2012 | 1.404M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Precigen, Inc. | 97.86M |
| Agenus, Inc. | 2.998M |
| Amgen, Inc. | 9.129B |
| Anika Therapeutics, Inc. | 57.48M |
| BioCryst Pharmaceuticals, Inc. | 274.95M |